Differential Expression of TGF-β Isoforms in Human Kerationocytes by Narrow Band UVB
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Transforming growth factor-β (TGF-β), a multifunctional growth factor, has three isoforms: TGF-β1, TGF-β2, and TGF-β3. Different isoforms of TGF-β are associated with different proliferation and differentiation states of the epidermis. Narrow band ultraviolet B (NBUVB) emits a concentrated UVB source of 311 nm. NBUVB 1,000 mJ/cm2 induces apoptosis in approximately 50% of keratinocytes. Objective: The purpose of this study was to evaluate whether irradiation with NBUVB would alter the expression and production of TGF-β1, 2, and 3. Methods: We measured TGF-β1, 2, and 3 mRNA and TGF-β1 and 2 protein levels at 800, 1,000, and 1,200 mJ/cm2 for 24 hours and 48 hours. Results: TGF-β1 mRNA levels were increased at both 24 hr and 48 hr, TGF-β2 mRNA levels were decreased at both 24 hr and 48 hr, and TGF-β3 mRNA levels were increased at 24 hr and similar to control at 48 hr. TGF-β1 protein levels were increased at 48 hr but decreased at 24 hr. TGF-β2 protein levels were decreased at both 24 hr and 48 hr. Conclusion: The results suggest a possible role for TGF-β1 after NBUVB irradiation and opposing roles for TGF-β1 and TGF-β2 isoforms in NBUVB irradiation. (Ann Dermatol (Seoul) 20(3) 113∼119, 2008)
Abstract
Background: Transforming growth factor-β (TGF-β), a multifunctional growth factor, has three isoforms: TGF-β1, TGF-β2, and TGF-β3. Different isoforms of TGF-β are associated with different proliferation and differentiation states of the epidermis. Narrow band ultraviolet B (NBUVB) emits a concentrated UVB source of 311 nm. NBUVB 1,000 mJ/cm2 induces apoptosis in approximately 50% of keratinocytes. Objective: The purpose of this study was to evaluate whether irradiation with NBUVB would alter the expression and production of TGF-β1, 2, and 3. Methods: We measured TGF-β1, 2, and 3 mRNA and TGF-β1 and 2 protein levels at 800, 1,000, and 1,200 mJ/cm2 for 24 hours and 48 hours. Results: TGF-β1 mRNA levels were increased at both 24 hr and 48 hr, TGF-β2 mRNA levels were decreased at both 24 hr and 48 hr, and TGF-β3 mRNA levels were increased at 24 hr and similar to control at 48 hr. TGF-β1 protein levels were increased at 48 hr but decreased at 24 hr. TGF-β2 protein levels were decreased at both 24 hr and 48 hr. Conclusion: The results suggest a possible role for TGF-β1 after NBUVB irradiation and opposing roles for TGF-β1 and TGF-β2 isoforms in NBUVB irradiation. (Ann Dermatol (Seoul) 20(3) 113∼119, 2008)
참고문헌 (15)
- Rao CL, "Linear IgA dermatosis and chronic bullous disease of childhood, In: Fitzpatrick's dermatology in general medicine", pp.587~592 (2003), McGraw-Hill
- Avci O, "Acetaminophennduced linear IgA bullous dermatosis", J Am Acad Dermatol, 48, pp.299~300 (2003)
- Bachot N, "Amiodarone-related linear IgA bullous dermatosis", J Am Acad Dermatol, 49, pp.E11~E12 (2003)
- Cerottini JP, "Drug-induced linear IgA bullous dermatosis probably induced by furosemide", J Am Acad Derm, 41, pp.103~105 (1999)
- Tran D, "Phenytoin-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis", Aus J Dermatol, 44, pp.284~286 (2003)
- Onodera H, "Drug-Induced linear IgA bullous dermatosis", J Dermatol, 32, pp.759~764 (2005)
- Waldman MA, "Vancomycininduced linear IgA bullous disease presenting as toxic epidermal necrolysis", Clin Exp Derm, 29, pp.633~636 (2004)
- Jones DH, "Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Steven-Johnson's syndrome", J Am Osteopath Assoc, 104, pp.157~163 (2004)
- Armstrong AW, "Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme", J Cutan Pathol, 31, pp.393~397 (2004)
- Palmer RA, "Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285", Br J Dermatol, 145(816)통권 : 820 (2001)
- 진현우, "Vancomycin에 의해 유발된 것으로 생각되는 선상 IgA 수포성 피부병 1예", 대한피부과학회지, 43(3), pp.416~418 (2005), 대한피부과학회
- Doh KS, "A case of vancomycin-induced linear IgA dermatosis", Korean J Dermatol, 40, pp.1132~1135 (2002)
- Zone JJ, "The 97kD linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180kDa bullous pemphigoid antigen, BPAg2", J Invest Dermatol, 110, pp.208~210 (1998)
- Wakelin SH, "Drug-induced linear IgA disease with antibodies to collagen VII", Br J Dermatol, 138, pp.310~314 (1998)
- Paul C, "Drug-induced linear IgA disease: target antigens are heterogenous", Br J Dermatol, 136, pp.406~411 (1997)